Skip to content
OpenCapital
Get started

Theriva Biologics TOVX Q4 2025 Annual earnings

Reported March 12, 2026 · After market close

EPS$1.85Beat by $2.29
EPS estimate-$0.44

Next report

Aug 12, 2026 (In 1 week)
Revenue estimate$300.0K
EPS estimate-$0.06

Versus estimates

Revenue

Q1 2026$300.0KIn lineQ4 2024$154.0K

Diluted EPS

Q1 2026-$0.05In line
Q4 2025$1.85Beat by $2.29
Q3 2025-$0.45Miss by $0.07Q2 2025-$1.93Miss by $1.55Q1 2025-$1.55Beat by $2.64Q4 2024-$3.30Beat by $3.06

Ask the moment Theriva Biologics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Theriva Biologics report Q4 2025 earnings?
Theriva Biologics (TOVX) reported Q4 2025 earnings on March 12, 2026 after market close.
What were Theriva Biologics's Q4 2025 revenue and EPS?
Theriva Biologics reported eps of $1.85 for Q4 2025.
Did Theriva Biologics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.43 by $2.29.
Where can I find Theriva Biologics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-026765) and the 10-K periodic report (0001104659-26-026767) directly on SEC EDGAR. The filing index links above go to sec.gov.